Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | SASH3 |
| Upstream (Parents) |
|---|
| (<<) IGSF6 → SASH3 |
| (<<) HLA-DMB → SASH3 |
| (<<) CD48 → SASH3 |
| (<<) GMFG → SASH3 |
| (<<) HCK → SASH3 |
| (<<) CD53 → SASH3 |
| Downstream (Children) |
|---|
| SASH3 → WWC1 (>>) |
| SASH3 → CLDN16 (>>) |
| SASH3 → ALOX15B (>>) |
| SASH3 → CD52 (>>) |
| SASH3 → KCNJ5 (>>) |
| SASH3 → CD1A (>>) |
| SASH3 → PTPN7 (>>) |
| SASH3 → PVRIG (>>) |
| SASH3 → MAPK14 (>>) |
| SASH3 → ZNF174 (>>) |
| SASH3 → MLLT4 (>>) |
| SASH3 → STAC (>>) |
| SASH3 → VAV1 (>>) |
| SASH3 → TWISTNB (>>) |
